2014
DOI: 10.4014/jmb.1308.08052
|View full text |Cite
|
Sign up to set email alerts
|

Improved Production of Medium-Chain-Length Polyhydroxyalkanoates in Glucose-Based Fed-Batch Cultivations of Metabolically Engineered Pseudomonas putida Strains

Abstract: One of the major challenges in metabolic engineering for enhanced synthesis of value-added chemicals is to design and develop new strains that can be translated into well-controlled fermentation processes using bioreactors. The aim of this study was to assess the influence of various fed-batch strategies in the performance of metabolically engineered Pseudomonas putida strains, Δgcd and Δgcd-pgl, for improving production of medium-chain-length polyhydroxyalkanoates (mcl-PHAs) using glucose as the only carbon s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
41
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(46 citation statements)
references
References 35 publications
4
41
1
Order By: Relevance
“…Among a list of different genetic targets, elementary flux mode analysis suggested an inactivation of glucose dehydrogenase encoded by gcd to prevent undesired by-product formation and excretion. In agreement with the prediction from the in silico model the constructed P. putida Δgcd mutant strain showed an increased PHA production in batch [13] and Fed-Batch cultivations [29]. Here, we continued to experimentally verify the predictions of our in silico model for the optimization of mcl-PHA production in P. putida .…”
Section: Introductionsupporting
confidence: 65%
See 1 more Smart Citation
“…Among a list of different genetic targets, elementary flux mode analysis suggested an inactivation of glucose dehydrogenase encoded by gcd to prevent undesired by-product formation and excretion. In agreement with the prediction from the in silico model the constructed P. putida Δgcd mutant strain showed an increased PHA production in batch [13] and Fed-Batch cultivations [29]. Here, we continued to experimentally verify the predictions of our in silico model for the optimization of mcl-PHA production in P. putida .…”
Section: Introductionsupporting
confidence: 65%
“…P. putida KT2440 can re-consume gluconate and 2-ketogluconate once secreted to the medium. We recently demonstrated that this process is not efficient to improve mcl-PHA synthesis [29], resulting in a lower volumetric PHA productivity as compared to the one shown by the Δ gcd P. putida mutant strain under the same growth conditions. Several investigations have shown that the volumetric productivity is the key parameter for the industrial production of PHAs and thus, any factor influencing this parameter affects the economics and cost competitiveness of PHAs synthesis via microbial fermentation [30-33].…”
Section: Resultsmentioning
confidence: 99%
“…It can be excluded that S. elongatus cscB is responsible for PHA formation since it lacks the corresponding genes for PHA synthesis [22]. Moreover, the distribution pattern of 3-hydroxyalkanoic acids is typical for P. putida (Table 2), with 3-hydroxydecanoic acid being the most abundant monomer [23]. Apparently, PHA was accumulated in only a small fraction of the cells, which can be deduced when comparing the CFU/mL to the cell counts of Nile red-stained cells.…”
Section: Resultsmentioning
confidence: 99%
“…Here, we reached a maximal concentration of ~150 mg/L PHA, which is quite low, compared to pure cultures. However, this was achieved with a small number of cells compared to the cell densities reached in pure cultures, which are normally cultivated in fed-batch, high-cell density processes [23]. Nevertheless, it is crucial for efficient downstream processing to obtain a high concentration of PHA.…”
Section: Resultsmentioning
confidence: 99%
“…CO 2 production rate based pulse feeding, cumulative CO 2 production based continuous feeding, etc.) have been proposed in the literature [5][6][7][8][9] . However, most of these strategies are focused on the KT2440 strain, which is different in terms of mcl-PHAs production from the rifampicin-resistant variant KT2442…”
Section: Introductionmentioning
confidence: 99%